Margherita Doria Selected Research

Margherita Doria Research Topics

9	Infections 01/2021 - 06/2013
7	Virus Diseases (Viral Diseases) 07/2019 - 09/2009
6	Neoplasms (Cancer) 06/2021 - 06/2013
5	Disease Progression 10/2017 - 11/2003
2	Lymphopenia (Lymphocytopenia) 01/2021 - 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 05/2022
1	Glioma (Gliomas) 05/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Persistent Infection 01/2021
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Zika Virus Infection 09/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Shock 01/2018
1	Opportunistic Infections (Opportunistic Infection) 06/2013
1	Vesicular Stomatitis 05/2007
1	Hepatitis B 09/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2003

8	LigandsIBA 06/2021 - 06/2013
3	Proteins (Proteins, Gene)FDA Link 09/2019 - 09/2005
3	Messenger RNA (mRNA)IBA 09/2019 - 01/2014
2	micaIBA 09/2019 - 06/2013
2	Antiviral Agents (Antivirals)IBA 01/2018 - 12/2013
2	CytokinesIBA 10/2017 - 01/2016
2	nef Gene Products (nef Gene Product)IBA 10/2011 - 11/2003
1	Transcription Factors (Transcription Factor)IBA 05/2022
1	Immunoglobulin M (IgM)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2020
1	NectinsIBA 07/2019
1	hexamethylene bisacetamide (HMBA)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	AntibodiesIBA 01/2018
1	L-SelectinIBA 01/2016
1	Fibronectins (Fibronectin)IBA 05/2015
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Ribosomal RNAIBA 01/2014
1	RNA Precursors (Precursor, mRNA)IBA 01/2014
1	Carrier Proteins (Binding Protein)IBA 06/2013
1	NK Cell Lectin-Like Receptor Subfamily KIBA 06/2013
1	RNA (Ribonucleic Acid)IBA 09/2009
1	Double-Stranded RNA (RNA, Double Stranded)IBA 09/2009
1	MHC class II transactivator proteinIBA 05/2007
1	invariant chain (Ii-Key)IBA 05/2007
1	Chloroquine (Aralen)FDA LinkGeneric 09/2005
1	VaccinesIBA 09/2005
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2003

2	Therapeutics 05/2022 - 01/2021
2	Highly Active Antiretroviral Therapy (HAART) 10/2017 - 06/2013
1	Art Therapy 01/2021
1	Immunotherapy 07/2019
1	Ligation 05/2015